A Study of 177Lu-DTPA-Omburtamab in Children and Adolescents With Brain Cancer or Cancer That Has Spread to the Central Nervous System (CNS)

NCT07698899 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Medulloblastoma
Refractory Medulloblastoma
CNS Metastases
Central Nervous System Metastasis

Interventions

BIOLOGICAL: 25 mCi 177Lu- DTPA-omburtamab

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]